Cancer immunotherapy company tries to explain deaths in recent trial – Science Magazine
Science Magazine |
Cancer immunotherapy company tries to explain deaths in recent trial
Science Magazine More than a year after five leukemia patients died from an experimental treatment involving genetically engineered immune cells, its developer believes it has a better handle on what went wrong—and possibly how to prevent a repeat of the tragedy. |
